Agilent NovoCyte Advanteon Flow Cytometer

The contract involves the acquisition of the Agilent NovoCyte Advanteon Flow Cytometer, a benchtop system designed for high-parameter cellular analysis, aimed at enhancing multicolor flow cytometry capabilities in both research and clinical laboratory environments. This advanced platform offers flexible hardware configurations along with automated data acquisition and analysis, facilitating more efficient and high-throughput experimental workflows. The instrument will support the Section on Regulatory Ribonucleic Acids in their research on gene expression regulation by RNA binding proteins and microRNAs, which is crucial for advancing understanding of disease mechanisms in cancer, hearing loss, and diabetes, ultimately contributing to the development of novel therapeutic strategies. The solicitation, identified as 75N98026Q00590, is posted by the National Institutes of Health under the Department of Health and Human Services, with the place of performance and office located in Bethesda, Maryland. The solicitation was posted on June 10, 2026, with a response deadline of June 22, 2026. There is no set-aside designation associated with this procurement. The primary point of contact for this opportunity is James B. Law, and the contract falls under NAICS code 334516, which pertains to analytical laboratory instrument manufacturing.